Italy Genome Editing Market Size & Outlook, 2024-2030
Italy genome editing market, 2018-2030 (US$M)
Related Markets
Italy genome editing market highlights
- The Italy genome editing market generated a revenue of USD 417.7 million in 2023 and is expected to reach USD 1,597.7 million by 2030.
- The Italy market is expected to grow at a CAGR of 21.1% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 417.7 million |
| Market revenue in 2030 | USD 1,597.7 million |
| Growth rate | 21.1% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Italy accounted for 5.2% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK genome editing market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 1,597.7 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 45.39% in 2024. Horizon Databook has segmented the Italy genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Recently, the Italian biotechnology industry has shown notable growth due to increasing academic and industrial research. Increasing research investments and initiatives in the country are anticipated to boost demand for advanced genome editing solutions for research applications.
Furthermore, the market is being driven by workshops, conferences, and events that are being organized regarding genome editing applications and issues. For instance, in November 2019, the International Center for Genetic Engineering and Biotechnology (ICGEB) and Joint Research Center, Italy, arranged a workshop to discuss genome editing and related technologies.
The workshop provided consultation on regulatory, societal, and ethical issues driven by technology & applications. In addition, the workshop intended to guide scientists working in their member states by providing practical skills.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy genome editing market size, by technology, 2018-2030 (US$M)
Italy Genome Editing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
